These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 9660794

  • 1. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ, Fredenburgh JC, Weitz JI.
    J Biol Chem; 1998 Jul 17; 273(29):18292-9. PubMed ID: 9660794
    [Abstract] [Full Text] [Related]

  • 2. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
    Stewart RJ, Fredenburgh JC, Rischke JA, Bajzar L, Weitz JI.
    J Biol Chem; 2000 Nov 24; 275(47):36612-20. PubMed ID: 10970891
    [Abstract] [Full Text] [Related]

  • 3. Structural features mediating fibrin selectivity of vampire bat plasminogen activators.
    Bringmann P, Gruber D, Liese A, Toschi L, Krätzchmar J, Schleuning WD, Donner P.
    J Biol Chem; 1995 Oct 27; 270(43):25596-603. PubMed ID: 7592732
    [Abstract] [Full Text] [Related]

  • 4. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
    Nesheim M, Fredenburgh JC, Larsen GR.
    J Biol Chem; 1990 Dec 15; 265(35):21541-8. PubMed ID: 2123871
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
    Lin LF, Houng A, Reed GL.
    Biochemistry; 2000 Apr 25; 39(16):4740-5. PubMed ID: 10769130
    [Abstract] [Full Text] [Related]

  • 9. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
    de Vries C, Veerman H, Koornneef E, Pannekoek H.
    J Biol Chem; 1990 Aug 15; 265(23):13547-52. PubMed ID: 2143185
    [Abstract] [Full Text] [Related]

  • 10. Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activator.
    Gardell SJ, Hare TR, Bergum PW, Cuca GC, O'Neill-Palladino L, Zavodny SM.
    Blood; 1990 Dec 15; 76(12):2560-4. PubMed ID: 2124935
    [Abstract] [Full Text] [Related]

  • 11. Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator.
    Dunn FW, Deguchi K, Soria J, Soria C, Lijnen HR, Tobelem G, Caen J.
    Thromb Res; 1984 Nov 15; 36(4):345-51. PubMed ID: 6543039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators.
    Toschi L, Bringmann P, Petri T, Donner P, Schleuning WD.
    Eur J Biochem; 1998 Feb 15; 252(1):108-12. PubMed ID: 9523718
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding.
    Weitz JI.
    J Vasc Interv Radiol; 1995 Feb 15; 6(6 Pt 2 Suppl):19S-23S. PubMed ID: 8770837
    [Abstract] [Full Text] [Related]

  • 16. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY, Fredenburgh JC, Stewart RJ, Rischke JA, Weitz JI.
    Thromb Haemost; 2001 Mar 15; 85(3):502-8. PubMed ID: 11307822
    [Abstract] [Full Text] [Related]

  • 17. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
    Gong Y, Kim SO, Felez J, Grella DK, Castellino FJ, Miles LA.
    J Biol Chem; 2001 Jun 01; 276(22):19078-83. PubMed ID: 11264290
    [Abstract] [Full Text] [Related]

  • 18. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator.
    Stewart RJ, Fredenburgh JC, Leslie BA, Keyt BA, Rischke JA, Weitz JI.
    J Biol Chem; 2000 Apr 07; 275(14):10112-20. PubMed ID: 10744692
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
    Kruithof EK, Schleuning WD.
    Thromb Haemost; 2004 Sep 07; 92(3):559-67. PubMed ID: 15351852
    [Abstract] [Full Text] [Related]

  • 20. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL, Chang BI, Wu DH, Chang LC, Gong CC, Lou KL, Shi GY.
    J Biol Chem; 1990 Nov 15; 265(32):19658-64. PubMed ID: 2174048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.